Skip to content
DraconiticResearch
Search Sources API
210,089 studies31 sourcesUpdated 55 min ago

Oncology

5,305 studies560 in 7 days2,549 in 30 days

Filters
Type
Date
Clear

Latest

5,305 studies

  1. An androgen-derived transcriptional state reveals signaling and mitochondrial vulnerabilities in cancer
    Y. Miao, T. Baba
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. The Spliceosome Scaffold Component BCAS2 Promotes Pancreatic Cancer Progression through Weak 5 Splice Site Dependent Splicing Regulation
    L. Wan, M. Wang, Y. Ishigami +5
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  3. Artesunate Exploits Glutathione-Dependent Redox Vulnerability in Metastatic Lung Adenocarcinoma
    P. Munteanu, S. Neuhaus, P. Feldt +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer
    M. Dorsch, F. E. G. Beaudry, A. K. Baginska +31
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. A Ribosomal RNA modification regulates translation of PI3K/AKT activators in high-grade serous ovarian carcinoma
    A. Rivera Pizana, L. Faucher-Giguere, M. S. Scott +1
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  6. A ribosomal pseudouridine drives an oncogenic translation program
    L. Faucher-Giguere, A. Rivera-Pizana, B. Seguineau de Preval +9
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  7. Receptor tyrosine kinase inhibitors trametinib and axitinib effectively target the neoplastic component of giant cell tumor of bone in vitro
    V. Knechtova, M. Mahdal, I. Staniczkova Zambo +5
    bioRxivPreprintCC BY-NDFull textOncologybioRxiv
  8. US-Guided Fine-Needle Aspiration of Papillary Thyroid Microcarcinoma in Non-Screening Settings: Diagnostic Errors and Mitigation Strategies
    I. EL HAG, M. T. Al Shammary, R. Tallab +2
    medRxivPreprintCC0Full textOncologymedRxiv
  9. Emerging antibody–drug conjugates in lung cancer: highlights from the 2026 ASCO Annual Meeting
    Xiaolei Wang, Jiayuan Miao, Yuxuan Bao +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  10. Network analysis of core symptom changes in hepatocellular carcinoma survivors after transarterial chemoembolization: A longitudinal study.
    Suping Wang, Xiuyan Wang, Ni Jiang +6
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  11. HSV-Net: hybrid state-space and self-supervised vision fusion with progressive contour learning for CT pulmonary nodule segmentation.
    Liang Cheng, Xinsheng Wan
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  12. Case Report: Solitary fibrous tumor of the pelvis associated with Doege-Potter syndrome.
    Xiaolong Tan, Weikai Dong, Wenli Chang +1
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  13. scTIME: single-cell-informed interpretable modeling of immunotherapy-associated immune states in non-small cell lung cancer.
    Guozhi Chen, Chenqiu You, Hong Gao +1
    Frontiers in artificial intelligencePeer-reviewedCC BYFull textOncologyEurope PMC
  14. Integrated CDK4/6 inhibitor resistance and primary-metastatic discordance in hormone receptor-positive/HER2-negative metastatic breast cancer: a translational framework focused on invasive ductal carcinoma with gastric metastasis.
    Minyi Cheng, Dongqing Wang, Yingyi Lin +4
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  15. Case Report: Diagnostic utility of pleural tissue debris retrieved during percutaneous drainage for the diagnosis of malignant pleural effusion and molecular profiling.
    Jiwon Kim, Han Gyeol Kim, Seung Hyeun Lee
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  16. Chemoresistance in cervical cancer: identifying and exploiting non-coding RNAs.
    Lilian Makgoo, Zukile Mbita
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  17. Prognostic value of postoperative dynamic PNI trajectories for biochemical recurrence in patients with high-risk localized prostate cancer: a longitudinal trajectory clustering study.
    Bo Yu, Xuchao Dai, Jianguo Zhu
    Frontiers in nutritionPeer-reviewedCC BYFull textOncologyEurope PMC
  18. Immune-related adverse events are associated with favorable clinical outcomes in esophageal cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
    Jiajia Fan, Dongmei Chen, Liqun Jia
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  19. Area-level socioeconomic deprivation and cause-specific survival after lung cancer diagnosis: a population-based cohort study in Naples, Italy.
    Arianna Scala, Sabrina Cristillo, Ilaria Loperto +3
    Frontiers in public healthPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  20. ‘It’s everybody’s business’: a multi-method study to co-develop and evaluate a web-based interprofessional Sexual Function Intimacy Concerns after Cancer educational programme (SexFICC) to upskill cancer healthcare providers
    Claudia Rutherford, Mary Hayes, Sharon De Graves +11
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textOncologyCrossref
  21. The CD160–HVEM axis at the crossroads of tolerance and immunity: lessons from cancer for autoimmunity and transplantation
    Shulin Sun, Lulin Ma
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  22. From CAF subtypes to clinically relevant states: cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
    Yi Hao, Yi Wang, Qinyang Du +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  23. Review on the significance and clinical application of anti-p53 autoantibody detection
    Fan Bu, Zhe-Nan Ling, Pei Li +14
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  24. Molecular mechanisms and therapeutic strategies of immunotherapy resistance in esophageal cancer
    Yiqian Pang, Panpan Jiang, Ke Liu +6
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  25. Towards epigenetically informed and biobank-driven precision immunotherapy in melanoma
    Ludovica Ciuffreda, Italia Falcone, Cristina Sorino +8
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC